Resistance rates of Staphylococcus aureus in relation to patient status and type of specimen

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 1, 2004, Pages 163-167

  Daxboeck, Florian ^a   Assadian, Ojan ^a   Apfalter, Petra ^a   Koller, Walter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antibiotic resistance; Blood culture isolates; MRSA; S. aureus; Surveillance

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; OXACILLIN; PENICILLIN G; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRIA; BACTERIUM ISOLATE; BLOOD CULTURE; BRONCHOSCOPY; CONTROLLED STUDY; HEALTH STATUS; HOSPITAL PATIENT; INTENSIVE CARE UNIT; MEDICAL ASSESSMENT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTPATIENT; RESPIRATORY TRACT EXAMINATION; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL; URINE CULTURE; WOUND;

DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OXACILLIN; PENICILLIN RESISTANCE; PENICILLINS; SPECIMEN HANDLING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 3543141197     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh277     Document Type: Article

References (13)

1. Bronzwaer, S. L., Buchholz, U., Kool, J. L. et al. (2001). EARSS activities and results: update. Euro Surveillance 6, 2-5.
2. Fritsche, T. R., Sader, H. S. & Jones, R. N. (2003). Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12, 295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002). Diagnostic Microbiology and Infectious Disease 47, 435-40.
3. Melzer, M., Eykyn, S. J., Gransden, W. R. et al. (2003). Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clinical Infectious Diseases 37, 1453-60.
4. Cordova, S. P., Heath, C. H., McGechie, D. B. et al. (2004). Methicillin-resistant Staphylococcus aureus bacteraemia in Western Australian teaching hospitals, 1997-1999: risk factors, outcomes and implications for management. Journal of Hospital Infection 56, 22-8.
5. National Committee for Clinical Laboratory Standards (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-Aa NCCLS, Villanova, PA, USA.
6. National Committee for Clinical Laboratory Standards (1994). Performance Standards for Antimicrobial Susceptibility Tests. Fifth Informational Supplement M100S5. NCCLS, Villanova, PA, USA.
7. Hartman, B. & Tomasz, A. (1981). Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 19, 726-35.
8. Lowy, F. D. (2003). Antimicrobial resistance: the example of Staphylococcus aureus. Journal of Clinical Investigation 111, 1265-73.
9. Archer, G. L. & Climo, M. W. (2001). Staphylococcus aureus bacteremia - consider the source. New England Journal of Medicine 344, 55-6.
10. Turnidge, J. & Collignon, P. (1999). Resistance to fusidic acid. International Journal of Antimicrobial Agents 12, Suppl. 2, S35-44.
11. Lautenschlager, S., Herzog, C. & Zimmerli, W. (1993). Course and outcome of bacteremia due to Staphylococcus aureus. evaluation of different clinical case definitions. Clinical Infectious Diseases 16, 567-73.
12. Vandenesch, F., Naimi, T., Enright, M. C. et al. (2003). Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerging Infectious Diseases 9, 978-84.
13. Okuma, K., Iwakawa, K., Turnidge, J. D. et al. (2002). Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. Journal of Clinical Microbiology 40, 4289-94.